Table 1.

Epidemiologic and clinical features in our cohort of young-adult liver transplanted patients.

Characteristics	Young-adult liver transplanted patients (n=33)
Male/Female, n	20/13
Original disease, n Biliary atresia Re-transplanted biliary atresia Alagille syndrome Metabolic disorders (MSUD, PA, OTCD) LKM-positive autoimmune hepatitis Hepatoblastoma Alpha-1 antitrypsin deficiency Congenital hepatic fibrosis Acute liver failure Cirrhosis	14 5 3 3 1 1 2 1 2 1
Post-transplant time, years	10.2 ± 5.6 (0.12-18.7)
Tacrolimus based immunosuppression, n	30
Tacrolimus blood levels, ng/ml	4.3 ± 1.4
Treatment combinations, n Tacrolimus Pred + Tacrolimus Pred + Tacrolimus + MMF Pred Pred + Cyclosporine	4 20 6 1 2
Dysfunctional/Normal graft, n	8/25
Median ALT, U/L	28

ALT, Alanine aminotransferase; MMF, mycophenolate mofetil; MSUD, Maple syrup urine disease; OTCD, Ornithine transcarbamylase deficiency; PA, Propionic academia; Pred, low dose methylprednisolone.